BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Diagnosis
13 results:

  • 1. 3D multifrequency magnetic resonance elastography in distinguishing endometrial and cervical adenocarcinoma.
    Long L; Liu M; Deng X; Cao M; Zhang J; Lan X; Zhang J
    Magn Reson Imaging; 2023 Oct; 102():62-68. PubMed ID: 37146780
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Using Silva pattern system to predict prognosis and plan treatment of invasive endocervical adenocarcinoma: a single-center retrospective analysis.
    Li X; Pang S; Shen Y; Qu P
    BMC Womens Health; 2022 Dec; 22(1):488. PubMed ID: 36460984
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma.
    Li Y; Jia M; Cao L; Yu J; Gao H; Sun PL
    BMC Cancer; 2022 Nov; 22(1):1172. PubMed ID: 36376880
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study.
    He Z; Xie C; Qi X; Hu Z; He Y
    BMC Womens Health; 2022 Jul; 22(1):314. PubMed ID: 35879712
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Endocervical Cytology: Inter- and Intra-Observer Variability in Conventional Pap Smears.
    Pulkkinen J; Huhtala H; Krogerus LA; Hollmén S; Laurila M; Kholová I
    Acta Cytol; 2022; 66(3):206-215. PubMed ID: 35226896
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Endocervical neoplasia: Pathologic updates in diagnosis and prognosis.
    Rivera-Colón G; Zheng W
    Semin Diagn Pathol; 2022 May; 39(3):213-227. PubMed ID: 34953647
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of clinical trait-related small RNA biomarkers with weighted gene co-expression network analysis for personalized medicine in endocervical adenocarcinoma.
    Shi Z; Qu X; Guo C; Zhang L; Peng C; Xie Z; Hua K; Qiu J
    Aging (Albany NY); 2021 Sep; 13(18):22361-22374. PubMed ID: 34542422
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and diagnosis of Pattern of Invasion: Evaluation of Participant Performance.
    Park KJ; Cabrero IA; Fadare O; Hoang L; Kiyokawa T; Oliva E; Parra-Herran C; Rabban JT; Roma A; Singh N; Soslow R; Stolnicu S; Huvila J; Leung S; Gilks CB
    Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S14-S23. PubMed ID: 33570861
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Feasibility of intravoxel incoherent motion diffusion-weighted imaging in distinguishing adenocarcinoma originated from uterine corpus or cervix.
    Zhang Q; Ouyang H; Ye F; Song Y; Xie L; Zhao X; Yu X
    Abdom Radiol (NY); 2021 Feb; 46(2):732-744. PubMed ID: 32671441
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cytology and curetting diagnosis of endocervical adenocarcinoma.
    Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
    J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Patterns of Invasion of cervical Adenocarcinoma as Predicators of Outcome.
    Roma AA
    Adv Anat Pathol; 2015 Nov; 22(6):345-54. PubMed ID: 26452210
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
    Pallardy A; Bodet-Milin C; Oudoux A; Campion L; Bourbouloux E; Sagan C; Ansquer C; Testard A; Resche I; Bridji B; Kraeber-Bodéré F; Rousseau C
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1270-8. PubMed ID: 20306032
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Sensitivity and specificity of the Pap smear for glandular lesions of the cervix and endometrium.
    Geldenhuys L; Murray ML
    Acta Cytol; 2007; 51(1):47-50. PubMed ID: 17328495
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.